Companies
- Companies
- Browse
Companies
Muti-disciplinary institute with neuroscience, cancer and cardiovascular research toghether with medicinal chemistry expertise More
Nanogenics Solutions is the exclusive licensee to the vector system (LipTide™) developed by University College London (UCL) for targeted delivery of DNA, RNA, peptides and drugs into cells. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Aug 2010 - 32 pages - $250
Aug 2010 - 35 pages - $250
Feb 2010 - 68 pages - $995
Aug 2011 - 45 pages - $1,500
Mar 2011 - 79 pages - $795
Feb 2010 - 68 pages - $995
Mar 2011 - 86 pages - $795
Feb 2010 - 56 pages - $745
Mar 2011 - 79 pages - $995
Feb 2010 - 54 pages - $745
Your selection
Browse By
- Industry sector
- Antibodies
- Antigens
- Biomarkers
- Cell lines
- Mouse models
- Reagents
- Vectors
- Therapeutic target
- Birth defects
- Blood clotting disorders
- Fabry's disease
- Gaucher's disease
- Genetic disorder (other)
- Hunter's syndrome
- Huntington's disease
- Kawasaki disease
- Klinefelter's syndrome
- Phenylketonuria
- Severe combined immunodeficiency
- Turner's syndrome
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us